Skip to main content
Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · IEX Real-Time Price · USD
47.10
-0.41 (-0.86%)
At close: May 17, 2024, 4:00 PM
48.05
+0.95 (2.02%)
After-hours: May 17, 2024, 5:44 PM EDT

Janux Therapeutics Revenue

Janux Therapeutics had revenue of $7.29M in the twelve months ending March 31, 2024, down -19.67% year-over-year. Revenue in the quarter ending March 31, 2024 was $1.25M, a -38.87% decrease year-over-year. In the year 2023, Janux Therapeutics had annual revenue of $8.08M, a decrease of -6.14%.

Revenue (ttm)
$7.29M
Revenue Growth
-19.67%
P/S Ratio
336.14
Revenue / Employee
$107,162
Employees
68
Market Cap
2.45B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20238.08M-529.00K-6.14%
Dec 31, 20228.61M4.98M136.79%
Dec 31, 20213.64M--
Dec 31, 20200--
Dec 31, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Patterson Companies 6.57B
Fortrea Holdings 3.11B
ICU Medical 2.26B
Indivior 1.12B
ACADIA Pharmaceuticals 813.81M
NovoCure 525.66M
RxSight 101.10M
Rhythm Pharmaceuticals 91.93M
Revenue Rankings

JANX News

More News